期刊文献+

短发夹RNA/mdr1表达载体的构建及体外表达 被引量:3

Construction of pSUPER-shRNA/mdr1 and its expression in vitro
原文传递
导出
摘要 目的构建短发夹RNA(shRNA)/mdr1的质粒表达载体并验证其体外表达效率。方法按照pSUPER的设计要求合成mdr1基因RNAi靶序列的64bp寡核苷酸序列,退火后双酶切法(BglⅡ和HindⅢ)克隆,得到质粒pSUPER-shRNA/mdr1,转染感受态大肠杆菌,筛选阳性克隆,测序证实后扩增培养并提取,然后转染融合达90%以上的HepG2/mdr1细胞,阴性载体为对照组,实时聚合酶链反应(Real-timePCR)、流式细胞术检测mdr1基因mRNA、P-gp表达、细胞耐药性等功能变化。结果成功构建质粒载体pSUPER-shRNA/mdr1,基因测序证实靶序列插入正确;HepG2/mdr1-si组mdr1基因的mRNA表达水平是耐药株HepG2/mdr1组的56分之一;HepG2/mdr1-si组细胞和阴性对照组HepG2/mdr1细胞的P-gP表达率分别为11.0%和98.6%,P〈0.05;HepG2/mdr1组细胞耐药倍数从62.5下降到1.4,相对逆转效率99.34%;细胞内DNR累积量也明显增加,与对照组比较(79.32%比37.96%),P〈0.05。结论多药耐药基因mdr1质粒表达载体pSU-PER-shRNA/mdr1能在HepG2/mdr1内稳定表达,并逆转其耐药性。 Objective To construct the expressing vector of shRNA/mdr1 and to study its reversed effect in vitro. Methods 64 bp oligonucleotides of pSUPER and the targeted sequence of siRNA/mdr1 were synthesized and annealed to form duplex strand, then were cloned into pSUPER to construct pSUPER-shRNA/mdr1 vector. Competent E. coli was transfected by vector of pSUPER-shRNA/mdr1 to screen the positive clones for sequencing and extracting plasmid. The plasmids extracted were used to transfect HepG2/mdr1 cells with control groups by negative vectors. The expression of mRNA was measured by real-time PCR, and P-glycoprotein and resistance of HepG2/mdr1 by flow cytometry. Results pSUPER-shRNA/mdr1 was established successfully and was sequenced to test its accuracy. The expression of mRNA in HepG2/mdr1-si was lower than that in HepG2/mdr1 (1-fold vs 56.30-fold,P 〈0.01 ). Compared to HepG2/mdr1, the expression of P-gp in HepG2/mdr1-si was lower (11% vs 98.6% ,P 〈 0.05 ). The sensitivity of HepG2/mdr1-si to adiramycin was higher than that of HepG2/mdr1 (62.5-fold vs 1,4-fold,P 〈0.01 ). Also, compared to controls, the accumulation of DNR in HepG2/mdr1-si was increased significandy (79.32% vs 37.96%, P 〈 0.05). Conclusion Vector of pSUPER-shRNA/mdr1 can be constructed by technique of enzymatic incision. The multidrug resistance of HepG2/mdr1 can be reversed.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2007年第2期169-172,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30170925)
关键词 多药耐药基因 质粒 表达 Multidyry gene Plasmid Expression
作者简介 潘光栋(现在广西医科大学第五附院肝胆外科,545001)
  • 相关文献

参考文献9

  • 1Parkin DM,Pisani P,Ferlay J.Estimates of the worldwide incidence of 25 major cancers in 1990.Int J Cancer,1999,80:827-841.
  • 2Chang G,Roth CB.Structure of msbA from E.coli:A homolog of the multidrug resistance ATP binding cassette (ABC) transporters.Science,2001,293:1793.
  • 3Izquierdo M.Short interfering RNAs as a tool for cancer gene therapy.Cancer Gene Ther,2005,12:217-227.
  • 4郜永顺,陈孝平.肝细胞癌多药耐药机制及其逆转策略研究进展[J].中华实验外科杂志,2006,23(4):639-640. 被引量:7
  • 5李臣宾 ,张峰 ,史玉荣 ,魏熙胤 ,杨毅 ,牛瑞芳 .小干扰RNA引发多药耐药乳腺癌细胞内MDR1基因沉默的研究[J].中华实验外科杂志,2004,21(10):1199-1201. 被引量:18
  • 6Hammond SM,Bemstein E,Beach D,et al.An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.Nature,2000,404:293 -296.
  • 7Caplen NJ,Parrisb S,Irnaru F,et al.Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.Proc Nat Acad Sci USA,2001,98:742-747.
  • 8Neith C,Priebsch A,Stage A,et al.Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).FEBS lett,2003:144-150.
  • 9Koper-emde D,Herrmann L,Sandrock B,et al.RNA interference by small hairpin RNAs synthesised under control of the human 7S K RNA promoter.Biol Chem,2004,385:791-794.

二级参考文献28

  • 1Xu D,Ye D,Fisher M,et al.Selective inhibition of P-glycoprotein expression in multidrug-resistant tumor cells by a designed transcriptional regulator.J Pharmacol Exp Ther,2002,302:963-971.
  • 2Mechetner EB,Roninson IB.Efficient inhibition of P-Glycoprotein-Mediated multidrug resistance with a monoclonal antibody.PNAS,1992,89:5824-5828.
  • 3Astriab-Fisher A,Sergueev DS,Fisher M,et al.Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates.Biochem Pharmacol,2000,60:83-90.
  • 4Pan L,Tong Y,Jin Y,et al.Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.Chin Med J (Engl),2001,114:929-932.
  • 5Yang JM,Vassil AD,Hait WN.Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway.Mol Pharmacol,2001,60:674-680.
  • 6Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature,1998,391:806-811.
  • 7McManus MT,Sharp PA.Gene silencing in mammals by small interfering RNAs.Nat Rev Genet,2002,3:737-747.
  • 8Tsang WP,Chau SP,Fung KP,et al.Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2cella.Cancer Chemother Pharmacol,2003,51:161-166.
  • 9Cheng AL,Chuang SE,Fine RL,et al.Inhibition of themembrane translocation and activation of protein kinase C,andpotentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cellsby tamoxifen.Biochem Pharmacol,1998,55:523-531.
  • 10Miyamoto K,Wakabayashi D,Minamino T,et al.Characterization of naturally acquired multiple-drug resistance of Yoshida ratascites hepatoma AH66 cell line.Anticancer Res,1996,16:1235-1240.

共引文献23

同被引文献30

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部